Immunogenicity 11188
Sample ID
3716
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ATF4
Transcript ID
None
HLA INFO
B*15:01
TCR INFO
No TCR info found!
Full length protein sequence (351 aa)
MTEMS
1
FLSSE
6
VLVGD
11
LMSPF
16
DQSGL
21
GAEES
26
LGLLD
31
DYLEV
36
AKHFK
41
PHGFS
46
SDKAK
51
AGSSE
56
WLAVD
61
GLVSP
66
SNNSK
71
EDAFS
76
GTDWM
81
LEKMD
86
LKEFD
91
LDALL
96
GIDDL
101
ETMPD
106
DLLTT
111
LDDTC
116
DLFAP
121
LVQET
126
NKQPP
131
QTVNP
136
IGHLP
141
ESLTK
146
PDQVA
151
PFTFL
156
QPLPL
161
SPGVL
166
SSTPD
171
HSFSL
176
ELGSE
181
VDITE
186
GDRKP
191
DYTAY
196
VAMIP
201
QCIKE
206
EDTPS
211
DNDSG
216
ICMSP
221
ESYLG
226
SPQHS
231
PSTRG
236
SPNRS
241
LPSPG
246
VLCGS
251
ARPKP
256
YDPPG
261
EKMVA
266
AKVKG
271
EKLDK
276
KLKKM
281
EQNKT
286
AATRY
291
RQKKR
296
AEQEA
301
LTGEC
306
KELEK
311
KNEAL
316
KERAD
321
SLAKE
326
IQYLK
331
DLIEE
336
VRKAR
341
GKKRV
346
P
351
Mutation Information
DNA mutation:
None
Peptide Range:
10 ~ 34
Mut AA position:
22 (13 in Wild Type peptide)
Alignment
Wild Type:
"EVLVGDLMSPFDQSGLGAEESLGLL
||||||||||||.||||||||||||
Mutant:
EVLVGDLMSPFDPSGLGAEESLGLL"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) ATF4
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay